Dr. Wojcieszek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 University Blvd
Indianapolis, IN 46202Phone+1 317-274-8800Fax+1 317-962-2141
Education & Training
- University of Iowa Hospitals and ClinicsResidency, Neurology, 1989 - 1992
- University of Iowa Hospitals and ClinicsInternship, Internal Medicine, 1988 - 1989
- The University of Toledo College of MedicineClass of 1988
Certifications & Licensure
- IN State Medical License 1995 - 2025
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) Start of enrollment: 2009 Sep 01
- Development of the Virtual Unified Huntington's Disease Rating Scale Start of enrollment: 2022 Sep 22
Roles: Contact
Publications & Presentations
PubMed
- 86 citationsA randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael P. McDermott, Karl Kieburtz, Elisabeth A. deBlieck, Flint Beal
Neurology. 2017-01-10 - 240 citationsA Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of BenefitM. Flint Beal, David Oakes, Ira Shoulson, Claire Henchcliffe, Wendy R. Galpern
JAMA Neurology. 2014-05-01 - 170 citationsA randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson diseaseKarl Kieburtz, Bernard Ravina, Wendy R. Galpern, Barbara C. Tilley, Kathleen M. Shannon
Neurology. 2007-01-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: